Clariant (OTCMKTS:CLZNY) Upgraded at Zacks Research

Zacks Research upgraded shares of Clariant (OTCMKTS:CLZNYFree Report) from a strong sell rating to a hold rating in a research report released on Tuesday,Zacks.com reports.

A number of other equities analysts have also weighed in on the stock. Morgan Stanley lowered shares of Clariant from an “overweight” rating to an “underweight” rating in a research note on Monday. The Goldman Sachs Group raised Clariant from a “strong sell” rating to a “hold” rating in a research report on Monday, June 15th. Four research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Reduce”.

Read Our Latest Research Report on CLZNY

Clariant Stock Performance

Shares of CLZNY stock opened at $9.70 on Tuesday. Clariant has a 52 week low of $8.45 and a 52 week high of $12.16. The company’s 50 day moving average price is $9.70 and its two-hundred day moving average price is $9.94.

About Clariant

(Get Free Report)

Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.

The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.

Further Reading

Analyst Recommendations for Clariant (OTCMKTS:CLZNY)

Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.